Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression

Background: Depression, the leading cause of disability worldwide, is a chronic disease characterized by a relapsing-remitting course. Acute treatments such as electroconvulsive therapy, ketamine, and repetitive transcranial magnetic stimulation are often effective at initiating remission, but relap...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew D. Geoly, Katy H. Stimpson, Flint M. Espil, Brandon S. Bentzley, Nolan R. Williams
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Brain Stimulation
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X25000877
Tags: Add Tag
No Tags, Be the first to tag this record!